Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Kevin Rodondi, PharmD

Photo of Kevin Rodondi, PharmD
Title(s)Professor Emeritus, Clinical Pharmacy
SchoolSchool of Pharmacy
Emailkevin.rodondi@ucsf.edu
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of California, San FranciscoPHA Primary Practice Residency1986 Pharmacy
    University of California, San FranciscoPharm.D.1985 Pharmacy

    Collapse Overview 
    Collapse overview
    Kevin Rodondi, Pharm.D. is Clinical Professor Emeritus of Pharmacy at the University of California San Francisco (UCSF) where he taught entrepreneurship and leadership in the School of Pharmacy and was the Associate Director of Leadership at the Healthforce Center. He was a national instructor for the NSF I-Corps Program, Domain Expert in Therapeutics for the NIH I-Corps Program and helped launch the first cohort of the NSF Convergence Accelerator as the Head Coach. Prior to the joining the faculty at UCSF he was a serial entrepreneur in healthcare and a member of the founding management team or co-founder of multiple companies including Access Biotechnology, the Oncology Therapeutics Network, and the National Oncology Alliance. He has mentored hundreds of early-stage entrepreneurs with STEM technologies in multiple disciplines nationally and continues to do so. He currently volunteers as a mentor with the growing innovation ecosystem in Hawaii including the HITIDE program at the University of Hawaii at Manoa and the Hawaii Technology Development Corporation (HTDC). Dr. Rodondi received a B.A. in physiology and chemistry from San Francisco State University, his Pharm.D. from UCSF, and completed two years of post-doctoral residency at UCSF.
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. What Is a Medication-Related Problem? A Qualitative Study of Older Adults and Primary Care Clinicians. J Gen Intern Med. 2020 03; 35(3):724-731. Nicosia FM, Spar MJ, Stebbins M, Sudore RL, Ritchie CS, Lee KP, Rodondi K, Steinman MA. PMID: 31677102; PMCID: PMC7080912.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    2. Evaluation of the ASCO Value Framework for Anticancer Drugs at an Academic Medical Center. J Manag Care Spec Pharm. 2017 Feb; 23(2):163-169. Wilson L, Lin T, Wang L, Patel T, Tran D, Kim S, Dacey K, Yuen C, Kroon L, Brodowy B, Rodondi K. PMID: 28125363; PMCID: PMC10397867.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    3. Doxorubicin multiple-dose vials. Am J Hosp Pharm. 1990 Sep; 47(9):1976-7. Rodondi KM. PMID: 2220843.
      View in: PubMed   Mentions:    Fields: